Exercise beat standard care for bone density in osteoporosis

Primary osteoporosis thins bone with age and brings pain that erodes quality of life. Conventional treatment is the standard response, and exercise is usually framed as a sensible add-on rather than a therapy in its own right. Whether structured exercise can actually match or beat conventional treatment on hard measures like bone mineral density has lacked a clear pooled answer, and the authors note the evidence has been insufficient. This review set out to gather every randomised trial on the question and weigh the evidence in one place.

The authors searched six databases, including PubMed, the Cochrane Library and Embase, for randomised controlled trials published up to April 2020. They included 20 trials with 1824 participants with primary osteoporosis. Trials compared exercise therapy against conventional treatment. The pooled outcomes were bone mineral density at the lumbar spine and femoral neck, pain measured on a visual analogue scale, and a panel of biochemical markers of bone metabolism such as alkaline phosphatase, serum calcium and serum phosphorus.

Exercise came out ahead of conventional treatment for bone mineral density at both the lumbar spine and the femoral neck, with statistically significant advantages reported. It also relieved pain more than conventional therapy did. The biochemical markers of bone metabolism were a different story: measures such as the collagen marker PINP, serum phosphorus, alkaline phosphatase and serum calcium showed no significant difference between groups. The individual trials also disagreed with each other substantially on most outcomes, which weakens confidence in the exact size of the effects.

Exercise is already understood to influence bone loss and pain in osteoporosis, but the strength of that evidence has been questioned. This pooled analysis nudges exercise from supportive habit towards genuine therapy, at least for bone density and pain. The authors themselves grade the underlying evidence as low quality, and the wide disagreement between trials leaves the true effect size uncertain. Whether exercise shifts the biology of bone turnover, as measured by blood markers, remains unconfirmed and is flagged as needing high-quality trials.

If bone health is on your mind, this is a reason to treat regular, structured exercise as more than a nice extra: in these pooled trials it outperformed conventional treatment on bone density and pain. It is not a reason to abandon prescribed treatment, and the shaky quality of the underlying studies means the size of the benefit is genuinely uncertain. The direction of the finding, though, clearly favours moving.